Filing Details
- Accession Number:
- 0001127602-23-000512
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-04 16:32:41
- Reporting Period:
- 2023-01-03
- Accepted Time:
- 2023-01-04 16:32:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1145197 | Insulet Corp | PODD | Surgical & Medical Instruments & Apparatus (3841) | 043523891 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1768648 | D. Wayde Mcmillan | C/O Insulet Corporation 100 Nagog Park Acton MA 01720 | Evp, Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-01-03 | 1,359 | $286.43 | 19,995 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan.
- The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $283.33 to $300. Specifically: 140 shares were sold in the range of $283.33 to $284.29, with a weighted average share price of $283.81; 490 shares were sold in the range of $284.58 to $285.39, with a weighted average share price of $285.10; 211 shares were sold in the range of $285.85 to $286.55, with a weighted average share price of $286.27; 230 shares were sold in the range of $286.64 to $287.40, with a weighted average share price of $286.92;
- Footnote continued:140 shares were sold in the range of $288.01 to $288.52, with a weighted average share price of $288.27; 138 shares were sold in the range of $290.48 to $290.49, with a weighted average share price of $290.49; 5 shares were sold at a price of $298.12 and 5 shares were sold at a price of $300. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.